DA Davidson Weighs in on USANA Health Sciences, Inc.’s FY2024 Earnings (NYSE:USNA)

USANA Health Sciences, Inc. (NYSE:USNA) – Research analysts at DA Davidson boosted their FY2024 earnings estimates for USANA Health Sciences in a note issued to investors on Tuesday, May 7th. DA Davidson analyst L. Weiser now forecasts that the company will post earnings of $2.75 per share for the year, up from their prior estimate of $2.70. DA Davidson has a “Neutral” rating and a $46.00 price objective on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.75 per share. DA Davidson also issued estimates for USANA Health Sciences’ FY2025 earnings at $2.90 EPS.

Separately, StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Friday, January 12th.

USANA Health Sciences Stock Performance

Shares of USANA Health Sciences stock opened at $45.07 on Thursday. The company has a market capitalization of $865.34 million, a PE ratio of 14.04, a P/E/G ratio of 1.38 and a beta of 0.94. The company has a 50-day simple moving average of $46.42 and a two-hundred day simple moving average of $48.05. USANA Health Sciences has a one year low of $41.45 and a one year high of $69.60.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, February 6th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.35. The business had revenue of $221.08 million during the quarter, compared to the consensus estimate of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%.

Institutional Trading of USANA Health Sciences

A number of large investors have recently made changes to their positions in the company. Quest Partners LLC acquired a new position in USANA Health Sciences in the fourth quarter valued at $66,000. CWM LLC grew its holdings in shares of USANA Health Sciences by 49.6% during the fourth quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after buying an additional 420 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in USANA Health Sciences by 60.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after acquiring an additional 1,274 shares during the period. Trexquant Investment LP acquired a new stake in USANA Health Sciences during the 4th quarter worth approximately $266,000. Finally, Teacher Retirement System of Texas purchased a new position in shares of USANA Health Sciences in the 3rd quarter valued at approximately $297,000. 54.25% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Robert A. Sinnott sold 3,945 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $46.55, for a total transaction of $183,639.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Robert A. Sinnott sold 3,945 shares of USANA Health Sciences stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $46.55, for a total value of $183,639.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Daniel A. Macuga sold 3,791 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total transaction of $178,707.74. The disclosure for this sale can be found here. Insiders have sold a total of 34,286 shares of company stock worth $1,634,010 over the last 90 days. 0.33% of the stock is currently owned by corporate insiders.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.